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OBJECTIVES
The objectives of this study were to compare the colonization and prevalence rates in the nations
of the United States, Sweden and Syria, with each country being representative of different
demographics and treatment methods and to analyze the healthcare practices of each nation,
specifically the rates at which each nation prescribes specific broad and narrow-spectrum
antibiotics. Also, this study aimed to assess the refugee crisis, which has caused a massive
migration of Syrians to Sweden, to make inquiries regarding the state of MRSA in nations like
Sweden. The culmination of this research is the question does the way the United States
prescribes antibiotics allow for more MRSA infections to occur and what future practices can
be used to help make MRSA a less dangerous pathogen in all demographics?
METHODS
This was primarily a study which synthesized data from various reports and resources to form a
coherent overview of MRSA infection patterns and propose further research methods for future
studies. To represent various demographics and methods of MRSA treatment three nations were
chosen. Sweden and the United States were identified as developed nations with similar wealth
and MRSA colonization rates but different prevalence (7, 8). Syria was chosen to be compared to
the United States and Sweden because it has a high documented MRSA colonization rate and is
the source of large numbers of refugees who are fleeing to countries like Sweden (4, 8). Studies
were then reviewed that documented several aspects of the MRSA threat in these nations,
including methods of testing, diagnosis and treatment. The data obtained was interpreted so that
conclusions could be drawn and further research objectives could be proposed.

RESULTS AND FIGURES

Table 1. Background information on demographics and
economics in United States, Sweden and Syria (8).

Table 2. The effects of the Syrian Civil War (7, 8).

Figure 1. Colonization of MRSA by nation.
MRSA colonization rates were based on official statistics presented by the CDC
and CDDEP in the case of the United States and Sweden. The colonization rate for
Syria was acquired by using congruent first hand studies and cross-referencing the
rates found with known rates of colonization amongst well documented Syrian
refugee populations in other countries. (4, 5, 6).

Figure 2. Prevalence of MRSA in the United States and Sweden.
The United States displays a MRSA prevalence of 2.6 infections per
10,000 people. Sweden has 0.3 MRSA infections per 10,000 people
equating to a rate that is 8 times lower than the United States’ despite
similar colonization rates (3, 6).

Figure 3. Antibiotic prescription trends in Sweden and the United States.
Broad-spectrum antibiotic prescription rates are much higher in the United
States than in Sweden. In contrast, Sweden prescribes narrow-spectrum
antibiotics at a much higher rate (6). Syria (not shown) has rates of
prescription which are hard to quantify as antibiotics are often unavailable,
used incorrectly or recycled from past infections (1).

It was found that the United States and Sweden are on par in terms of wealth and MRSA
colonization rate (2-4%). Syria, for various reasons, possesses a much higher colonization rate
(15-20%) meaning that its population comes in contact with MRSA much more frequently (4, 7).
Despite similarities, people in the United States are eight times as likely to develop a MRSA
infection than people in Sweden (3, 6). Syria also has a problem with the availability and misuse
of antibiotics that contributes to high colonization and infection rates of MRSA and other
pathogens (1). The United States prescribes broad-spectrum antibiotics at much higher rates than
Sweden does which would indicate that patients in the United States are subject to more depleted
normal flora (7). Conversely, Sweden prescribes narrow-spectrum antibiotics at rates that far
surpass the United States and Syria (7). Syrians are moving to Sweden in the midst of a refugee
crisis at unprecedented rates (7, 8).
DISCUSSION
The United States and Sweden are similar enough in terms of wealth and development that it can
be expected that they would have access to the same quality healthcare facilities, education and
techniques that other countries, like Syria, may not be able to access for varying circumstances
(8). It may be theorized that the difference in rates of infection between the United States and
Sweden is a partial product of the way antibiotics are used in each country. The United States’
high use of broad-spectrum treatments would mean that patients in the United States are more
likely to have significant portions of their normal flora inhibited (7). Since MRSA is
opportunistic, patients with compromised normal flora are prime targets for infection (2). In stark
contrast, Sweden’s high prescription rate of narrow-spectrum antibiotics is indicative of

increased antibiotic susceptibility testing (7). Prescribing antibiotics with mechanisms of action
for specific infections rather than indiscriminately attacking pathogenic and normal flora is likely
a contributing factor to Sweden’s low MRSA infection prevalence. While reliable data on MRSA
in Syria is harder to obtain, the trend is clear that the sociopolitical conditions of the country are
exacerbating the problems of MRSA. The worldwide migration trend of Syrians to other
countries should be watched closely and provides new avenues for healthcare service and
research as it pertains to MRSA and proper antibiotics use.
IMPLICATIONS FOR FUTURE STUDY
1. Further study on the methods of antibiotic susceptibility testing in Sweden and the United
States should be conducted. Can effective methods be translated into a setting in an
underserved area like Syria?
2. Tracking the immigration and MRSA colonization rates amongst Syrian refugees and the
European countries they enter.
3. This study neglected to analyze the cost-effectiveness of antibiotic susceptibility testing
in most cases and further research should focus on the economics of prescribing and
testing.
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